Closing the Generation Gap: Part 2 - Hemophilia Federation of America

Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

Managing Inhibitors in Hemophilia A: Treatment Strategies

Ukraine One-Year Report

Closing the Medicare Part D Coverage Gap: Trends, Recent Changes, and What's Ahead

Equity and access to care: join us for the WFH Global Summit on WGBD – WFH - World Federation of Hemophilia

History of Bleeding Disorders - Hemophilia Federation of America

Federal 340B Leader Moves On After 21 Months - 340B Report

Closing the gap in a generation: Health equity through action on the social determinants of health - PAHO/WHO

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors